479 related articles for article (PubMed ID: 15367885)
1. Orthotopic transplantation models of pancreatic adenocarcinoma derived from cell lines and primary tumors and displaying varying metastatic activity.
Loukopoulos P; Kanetaka K; Takamura M; Shibata T; Sakamoto M; Hirohashi S
Pancreas; 2004 Oct; 29(3):193-203. PubMed ID: 15367885
[TBL] [Abstract][Full Text] [Related]
2. DCC and SMAD4 alterations in human colorectal and pancreatic tumor dissemination.
Tarafa G; Villanueva A; Farré L; Rodríguez J; Musulén E; Reyes G; Seminago R; Olmedo E; Paules AB; Peinado MA; Bachs O; Capellá G
Oncogene; 2000 Jan; 19(4):546-55. PubMed ID: 10698524
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the mutations of the K-ras, p53, p16, and SMAD4 genes in 15 human pancreatic cancer cell lines.
Sun C; Yamato T; Furukawa T; Ohnishi Y; Kijima H; Horii A
Oncol Rep; 2001; 8(1):89-92. PubMed ID: 11115575
[TBL] [Abstract][Full Text] [Related]
4. Clinical, molecular and genetic validation of a murine orthotopic xenograft model of pancreatic adenocarcinoma using fresh human specimens.
Walters DM; Stokes JB; Adair SJ; Stelow EB; Borgman CA; Lowrey BT; Xin W; Blais EM; Lee JK; Papin JA; Parsons JT; Bauer TW
PLoS One; 2013; 8(10):e77065. PubMed ID: 24204737
[TBL] [Abstract][Full Text] [Related]
5. Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4.
Moore PS; Sipos B; Orlandini S; Sorio C; Real FX; Lemoine NR; Gress T; Bassi C; Klöppel G; Kalthoff H; Ungefroren H; Löhr M; Scarpa A
Virchows Arch; 2001 Dec; 439(6):798-802. PubMed ID: 11787853
[TBL] [Abstract][Full Text] [Related]
6. Immortalizing the complexity of cancer metastasis: genetic features of lethal metastatic pancreatic cancer obtained from rapid autopsy.
Embuscado EE; Laheru D; Ricci F; Yun KJ; de Boom Witzel S; Seigel A; Flickinger K; Hidalgo M; Bova GS; Iacobuzio-Donahue CA
Cancer Biol Ther; 2005 May; 4(5):548-54. PubMed ID: 15846069
[TBL] [Abstract][Full Text] [Related]
7. Establishment and characterisation of six human biliary tract cancer cell lines.
Ku JL; Yoon KA; Kim IJ; Kim WH; Jang JY; Suh KS; Kim SW; Park YH; Hwang JH; Yoon YB; Park JG
Br J Cancer; 2002 Jul; 87(2):187-93. PubMed ID: 12107841
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis.
Moore PS; Orlandini S; Zamboni G; Capelli P; Rigaud G; Falconi M; Bassi C; Lemoine NR; Scarpa A
Br J Cancer; 2001 Jan; 84(2):253-62. PubMed ID: 11161385
[TBL] [Abstract][Full Text] [Related]
9. Tumor-suppressive pathways in pancreatic carcinoma.
Rozenblum E; Schutte M; Goggins M; Hahn SA; Panzer S; Zahurak M; Goodman SN; Sohn TA; Hruban RH; Yeo CJ; Kern SE
Cancer Res; 1997 May; 57(9):1731-4. PubMed ID: 9135016
[TBL] [Abstract][Full Text] [Related]
10. Orthotopic xenografts of human pancreatic carcinomas acquire genetic aberrations during dissemination in nude mice.
Reyes G; Villanueva A; García C; Sancho FJ; Piulats J; Lluís F; Capellá G
Cancer Res; 1996 Dec; 56(24):5713-9. PubMed ID: 8971180
[TBL] [Abstract][Full Text] [Related]
11. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
12. [Expression of DPC4/Smad4, p21wafI, and p16 in human pancreatic cancer].
Gu LJ; Chen J; Lu ZH; Li L; Zhou WX; Luo YF
Ai Zheng; 2002 Feb; 21(2):132-7. PubMed ID: 12479060
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional profiling of cell lines derived from an orthotopic pancreatic tumor model reveals metastasis-associated genes.
Tarbé N; Evtimova V; Burtscher H; Jarsch M; Alves F; Weidle UH
Anticancer Res; 2001; 21(5):3221-8. PubMed ID: 11848476
[TBL] [Abstract][Full Text] [Related]
14. DPC4/Smad4 expression and outcome in pancreatic ductal adenocarcinoma.
Biankin AV; Morey AL; Lee CS; Kench JG; Biankin SA; Hook HC; Head DR; Hugh TB; Sutherland RL; Henshall SM
J Clin Oncol; 2002 Dec; 20(23):4531-42. PubMed ID: 12454109
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a newly established human pancreatic carcinoma cell line, UK Pan-1.
Fralix KD; Ahmed MM; Mattingly C; Swiderski C; McGrath PC; Venkatasubbarao K; Kamada N; Mohiuddin M; Strodel WE; Freeman JW
Cancer; 2000 May; 88(9):2010-21. PubMed ID: 10813711
[TBL] [Abstract][Full Text] [Related]
16. [General rules for the study of pancreatic cancer by molecular biological aspect].
Omata M; Tada M
Nihon Geka Gakkai Zasshi; 2000 Feb; 101(2):233-6. PubMed ID: 10734643
[TBL] [Abstract][Full Text] [Related]
17. Microcystic tubulopapillary carcinoma of the pancreas: a new tumor entity?
Esposito I; Bauer A; Hoheisel JD; Kleeff J; Friess H; Bergmann F; Rieker RJ; Otto HF; Klöppel G; Penzel R
Virchows Arch; 2004 May; 444(5):447-53. PubMed ID: 15014986
[TBL] [Abstract][Full Text] [Related]
18. Molecular pathobiology of pancreatic adenocarcinoma.
Mangray S; King TC
Front Biosci; 1998 Nov; 3():D1148-60. PubMed ID: 9820739
[TBL] [Abstract][Full Text] [Related]
19. K-ras, p53, and DPC4 (MAD4) alterations in fine-needle aspirates of the pancreas: a molecular panel correlates with and supplements cytologic diagnosis.
van Heek T; Rader AE; Offerhaus GJ; McCarthy DM; Goggins M; Hruban RH; Wilentz RE
Am J Clin Pathol; 2002 May; 117(5):755-65. PubMed ID: 12090425
[TBL] [Abstract][Full Text] [Related]
20. Tumor-suppressing pathways in cystic pancreatic tumors.
Gerdes B; Wild A; Wittenberg J; Barth P; Ramaswamy A; Kersting M; Lüttges J; Klöppel G; Bartsch DK
Pancreas; 2003 Jan; 26(1):42-8. PubMed ID: 12499916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]